se Law On Fake Medicine Scandals In Bangladesh
Fake Medicine Scandals in Bangladesh: Case Laws and Legal Action
Case 1: Khulna Fake Medicine Factory (2016)
Facts: A factory in Rupsha, Khulna, posed as a seafood plant but was producing fake medicines. They used rice powder and other substitutes instead of active ingredients, packaged under established pharmaceutical brands like ACI and Opsonin.
Legal Issue: Manufacturing and distributing fake medicines, mislabeling, and cheating.
Action Taken: The Rapid Action Battalion (RAB) raided the factory, seized fake medicines, and arrested key personnel including politically connected individuals.
Court Outcome: The accused were sent to jail; cases were filed under criminal provisions for cheating and fraud.
Significance: This case highlighted the criminal liability of individuals and networks behind fake medicine production, showing large-scale deception and public health risks.
Case 2: Rampura & Gulshan Fake Vaccine/Medicine Factories (2014)
Facts: Two illegal factories in Dhaka produced fake hepatitis vaccines and herbal medicines. One factory operated for about five years under the guise of a herbal medicine company.
Legal Issue: Illegal manufacturing of vaccines and medicines, endangering public health.
Action Taken: Authorities raided the factories, sealed them, and detained 14 individuals. One person from an NGO was sentenced to one year imprisonment for selling fake vaccines.
Significance: Demonstrates the diversity of fake medical products, including vaccines, and shows that even organizations posing as NGOs can be involved in fraud.
Case 3: Chittagong Fake Medicine Cache (2018)
Facts: A large cache of fake medicines was found in a rented house in Chittagong. The accused confessed to manufacturing and distributing fake medicines under multiple brand names. Collusion with some local doctors and diagnostic centers was also revealed.
Legal Issue: Fraudulent manufacture and distribution of medicines, possible collusion with healthcare professionals.
Action Taken: Police lodged a case and seized the medicines; further investigation was initiated.
Significance: Showed the networked nature of fake medicine distribution, linking manufacturers, distributors, and professionals.
Case 4: High Court Direction on Adulterated Medicines (2019)
Facts: Writ petitions were filed regarding repeated sale of expired, adulterated, and fake medicines. Mobile courts were giving negligible punishments, raising concern about public safety.
Legal Issue: Need for stricter punishment for producing and selling adulterated or fake medicines.
Court Action: The High Court directed authorities to prosecute repeat offenders under the Special Powers Act, 1974, and recommended life imprisonment or death penalty for severe offences.
Significance: Landmark guidance reinforcing the seriousness of fake medicine offences, elevating penalties beyond fines to life imprisonment for repeat offenders.
Case 5: Fake Diabetes Test Strips Case (2024)
Facts: A company imported and sold fake diabetes test strips under the brand of a reputable foreign company. The strips were not verified and posed a risk to diabetic patients.
Legal Issue: Import and sale of counterfeit medical diagnostic devices.
Court Action: The High Court ordered the DGDA to destroy the fake test strips within seven days.
Significance: Shows that not only medicines but diagnostic consumables are targeted by counterfeiters, and courts can take decisive action to prevent harm.
Case 6: Mohammadpur Fake Medicine Seizure (2019)
Facts: Mobile courts raided several pharmacies and godowns in Dhaka and seized fake medicines worth around 1 crore taka.
Legal Issue: Distribution and sale of counterfeit medicines in retail and wholesale markets.
Action Taken: Fines imposed, shops sealed, and arrests made.
Significance: Illustrates the scale of fake medicine operations in urban marketplaces and the role of mobile courts in enforcement.
Case 7: Bogura Herbal Medicine Fraud (2017)
Facts: A company in Bogura was producing herbal medicines falsely claiming them to cure chronic diseases such as diabetes and heart problems. Investigations revealed fake packaging and labels.
Legal Issue: Misrepresentation of medicinal efficacy, illegal manufacture, and distribution of herbal products.
Court Action: The company was shut down, the owners were prosecuted under laws regulating drugs and consumer protection.
Significance: Highlights that herbal and alternative medicines are also subject to fraudulent practices, showing the broad reach of fake medicine scandals.
Key Legal and Policy Takeaways
Common Patterns: Manufacturing counterfeit medicines, adulteration, mislabeling, collusion with distributors or medical professionals.
Applicable Laws:
Directorate General of Drug Administration regulations
Special Powers Act, 1974 for repeat offenders
Penal provisions for cheating, fraud, misrepresentation
Enforcement Mechanisms: RAB raids, mobile courts, DGDA actions, High Court directives.
Judicial Trends: Courts increasingly recognize fake medicine offences as extremely serious, sometimes recommending life imprisonment or capital punishment for severe or repeated violations.
Public Health Impact: Fake medicines can lead to treatment failure, organ damage, or death, making prosecution essential.
RELATED Blog
comments